To test whether Mocetinostat at the dose of 20 mg/kg/day induce apoptosis in CHF myocardium, we measured the number of positive cleaved-caspase-3 cells in the scar and LV of Mocetinostat-treated and untreated CHF animals (Supplementary Figure S1). This evidence concerns the gene CASP3 and congestive heart failure.